- Home
- SNTI vs ONEG Comparison
SNTI vs ONEG Comparison
Compare SNTI & ONEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNTI | ONEG |
|---|---|---|
| Founded | 2016 | 2021 |
| Country | United States | Hong Kong |
| Employees | N/A | 26 |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.5M | 28.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | SNTI | ONEG |
|---|---|---|
| Price | $0.86 | $2.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | 101.7K | ★ 417.8K |
| Earning Date | 05-05-2026 | 01-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.31 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7,627.27 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.77 | $0.96 |
| 52 Week High | $5.10 | $13.50 |
Technical Indicators
Market Signals| Indicator | SNTI | ONEG |
|---|---|---|
| Relative Strength Index (RSI) | 44.87 | 50.61 |
| Support Level | $0.80 | $1.93 |
| Resistance Level | $1.02 | $2.49 |
| Average True Range (ATR) | 0.06 | 0.34 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 40.73 | 75.33 |
Price Performance
Historical ComparisonAbout SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About ONEG OneConstruction Group Limited Ordinary Shares
OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. The company is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project includes performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.